Pres, COO at Adaptive Biotechnologies Corp Sells $897,356 in Stock

Julie Rubinstein, who serves as Pres, COO at Adaptive Biotechnologies Corp (ADPT), sold 35,643 shares of the company's stock, according to a disclosure filed with the U.S. Securities and Exchange Commission.

The transaction was executed at a price of $25.18 per share, for a total value of approximately $897,356.

Insider transactions of this kind are publicly disclosed through Form 4 filings with the SEC, which must generally be submitted within two business days of the trade date.

Insider sales are common and can occur for reasons unrelated to a company's outlook, including scheduled trading plans, diversification, or personal financial planning.